Patient Recruitment/Retention Featured Articles

1. What Happens When Clinical Trial Patients Need Care Outside Of The Study? 10/26/2026

   Clinical trial patients may need care outside of the trial protocol. Discover how closing information gaps can protect safety, trial participation, and data integrity.

2. Testing Early Treatment In Head And Neck Cancer Without Compromising Curative Care 10/20/2026

   Can early APG-157 treatment control head and neck cancer without delaying curative care? A Phase 3 trial puts timing, safety, and outcomes to the test.

3. Can Psychedelic‑Assisted Treatment Redefine Emotional Care In Oncology? 10/16/2026

   Psychedelic-assisted treatment may offer faster, lasting relief for cancer patients facing adjustment disorder, depression, and anxiety.

4. Can A Universal Health Screening Help Stop Clinical Trial Dropouts? 10/13/2026

   Could comprehensive health scans give trial participants meaningful value — and help sponsors reduce costly dropouts?

5. Participant Payment — Make It Make Cents 10/6/2026

   Participant payment practices and expectations vary wildly. With advocate T.J. Sharpe, explore why sponsors need to rethink how they appreciate participants' time, effort, and burden.

6. How Plain Language Summaries Created Under EU CTR Can Help Shape NIH Policy 9/30/2026

   As the NIH shapes its plain language summary policy, EU CTR experience offers practical lessons on clarity, privacy, consistency, and implementation.

7. Most Patients Learn About A Trial Online, But Is That What They Want? 9/30/2026

   Patients want to hear about clinical trials from their doctors — but most learn out online. CISCRP explores how industry can change the referral pathway for better.

8. Why Are We Still Talking About Compensating Research Participants? 9/28/2026

   Should we be compensating research participants? And is that even a question worth asking? Lindsay McNair, MD, and Ken Getz say yes despite recent data that doesn't point to a clear ROI.

9. Why Oncology Programs Can't Rely On An Inside View Alone 9/18/2026

   Discover how looking outside a program can help oncology teams test assumptions, improve feasibility, and make stronger development decisions.

10. The Promise Of MRD-Guided CAR-T Treatment 9/3/2026

    Minimal residual disease markers can reveal relapse before clinical signs appear, when off-the-shelf cell therapy may have its greatest advantage.